Henrik J. Ditzel

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (9)

morten gjerstorff

Professor

University of Southern Denmark

DENMARK

View details

Tenna Henriksen

Aarhus University

DENMARK

View details

Annette Raskov Kodahl

Odense University Hospital

DENMARK

View details

Colin Sumners

Professor Emeritus

University of Florida

UNITED STATES

View details

Claus Lindbjerg Andersen

Aarhus University

DENMARK

View details

U. Muscha Steckelings

University of Southern Denmark

DENMARK

View details

Mikkel Terp

Associate Professor

University of Southern Denmark

DENMARK

View details

Augusto Peluso

Københavns Universitet

DENMARK

View details

Mads Heilskov Rasmussen

VIP, Associate Professor

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Henrik J. Ditzel

Research Interests

Explore related searches

Contact this professor

Articles (14)

Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis

Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer

Correction: Mansoori et al. HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer. Cancers 2021, 13, 5197

Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer

Quantitative Phosphoproteomics of the Angiotensin AT 2 -Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer

ZBED1 Regulates Genes Important for Multiple Biological Processes of the Placenta.

Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer

Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models.

Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination.

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes

Resistance Mechanisms to Combined CDK4/6 Inhibitors and Endocrine Therapy in ER+/HER2− Advanced Breast Cancer: Biomarkers and Potential Novel Treatment Strategies

Collaborators (9)

morten gjerstorff

Tenna Henriksen

Annette Raskov Kodahl

Colin Sumners

Claus Lindbjerg Andersen

U. Muscha Steckelings

Mikkel Terp

Augusto Peluso

Mads Heilskov Rasmussen

Make your next move.